David B. Elsbree, Director at T2 Biosystems, Inc. (TTOO), bought 1,450 shares at $15.05 ($22K) on 2015-03-04, disclosed to the SEC on 2015-03-06.
Open-market purchase of $22k TTOO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| TTOO | SELL | 2019-06-13 | $5K | — | Filing → |
| TTOO | BUY | 2018-06-05 | $32K | — | Filing → |
| TTOO | BUY | 2017-11-17 | $6K | — | Filing → |